Back to search
FDAFDA · Food and drugs·Recall number Z-1293-2024

EasyPoint Needle, 25G x 5/8", REF: 82091

Published March 20, 2024 · Recall initiated: February 5, 2024

Summary

FDA records medical device Class II recall Z-1293-2024, published March 20, 2024 and initiated February 5, 2024. Recalling firm: Retractable Technologies, Inc.; Status: Ongoing; Reported quantity: 477,600; Lot: UDI-DI: 00613703820907. Lot: K220402. Expiration: 03/28/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The needle cannula of a retractable needle may detach from the needle holder in the patient.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Retractable Technologies, Inc.
Distributor
US Nationwide distribution including in the states of NY, FL, IL, MA, UT, NJ, AZ, MO, WA, NC, CA, TX, NV, IN, PA, VA, IA, GA, TN, MI, OH, OK, CO, OR, SC, MN, CT.
Lot
UDI-DI: 00613703820907. Lot: K220402. Expiration: 03/28/2027
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was EasyPoint Needle, 25G x 5/8", REF: 82091 recalled?

Yes. FDA published recall Z-1293-2024 on March 20, 2024. Reported hazard: The needle cannula of a retractable needle may detach from the needle holder in the patient.

What should I do if I have this product?

Voluntary: Firm initiated · Letter